Cassella James V

Avg. Two Year Performance

No purchase track record
36% Avg. Sale Return
17% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(2%)3%9%28%36%
Sale Success Rate2 of 103 of 103 of 103 of 104 of 10
Drugs » Drug Manufacturers - Other

Former EVP, R&D and CSO, Director:

Holdings: 62.49K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Chief Development Officer:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--